The Latest Analyst Ratings For Catalyst Pharmaceuticals
The Latest Analyst Ratings For Catalyst Pharmaceuticals
catalyst pharmaceuticals的最新分析师评级
The standing of...5 analysts have expressed a variety of opinions on Catalyst Pharmaceuticals (NASDAQ:CPRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有5位分析师对Catalyst Pharmicals（纳斯达克股票代码：CPRX）表达了各种观点，从看涨到看跌，提出了各种各样的观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Catalyst Pharmaceuticals and provided 12-month price targets. The average target is $29.2, accompanied by a high estimate of $31.00 and a low estimate of $26.00. Witnessing a positive shift, the current average has risen by 9.77% from the previous average price target of $26.60.
分析师最近对Catalyst Pharmicals进行了评估，并提供了12个月的价格目标。平均目标为29.2美元，最高估计值为31.00美元，低估值为26.00美元。当前的平均价格从之前的26.60美元平均目标股价上涨了9.77％，这是一个积极的转变。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
The standing of...
通过对...
登录免费看全文
登录/注册
资讯热榜
更新时间